Hla Timothy, Venkataraman Krishnan, Michaud Jason
Center for Vascular Biology, Department of Cell Biology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06001, USA.
Biochim Biophys Acta. 2008 Sep;1781(9):477-82. doi: 10.1016/j.bbalip.2008.07.003. Epub 2008 Jul 28.
Sphingosine 1-phosphate (S1P), a product of sphingomyelin metabolism, is enriched in the circulatory system whereas it is estimated to be much lower in interstitial fluids of tissues. This concentration gradient, termed the vascular S1P gradient appears to form as a result of substrate availability and the action of metabolic enzymes. S1P levels in blood and lymph are estimated to be in the muM range. In the immune system, the S1P gradient is needed as a spatial cue for lymphocyte and hematopoietic cell trafficking. During inflammatory reactions in which enhanced vascular permeability occurs, a burst of S1P becomes available to its receptors in the extravascular compartment, which likely contributes to the tissue reactions. Thus, the presence of the vascular S1P gradient is thought to contribute to physiological and pathological conditions. From an evolutionary perspective, S1P receptors may have co-evolved with the advent of a closed vascular system and the trafficking paradigms for hematopoietic cells to navigate in and out of the vascular system.
鞘氨醇-1-磷酸(S1P)是鞘磷脂代谢的产物,在循环系统中含量丰富,而据估计在组织的间质液中含量要低得多。这种浓度梯度,即所谓的血管S1P梯度,似乎是由于底物可用性和代谢酶的作用而形成的。血液和淋巴中的S1P水平估计在微摩尔范围内。在免疫系统中,S1P梯度作为淋巴细胞和造血细胞迁移的空间线索是必需的。在发生血管通透性增强的炎症反应期间,大量的S1P可作用于血管外区域的受体,这可能有助于组织反应。因此,血管S1P梯度的存在被认为与生理和病理状况有关。从进化的角度来看,S1P受体可能随着封闭血管系统的出现以及造血细胞在血管系统中进出的迁移模式而共同进化。